KAEF — Income Statement (Laba Rugi)
Laporan Keuangan Ringkasan laba rugi, neraca, dan arus kas — KAEF Kimia Farma Tbk.
| Dalam Jutaan IDR | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total Pendapatan | 2,030,649 | 9,223,328 | 7,008,211 | 4,369,349 | 2,168,208 | 9,938,958 | 7,864,264 | 5,213,695 | 2,535,779 |
| Total Beban Pokok Penjualan | (1,205,833) | (6,159,918) | (4,563,132) | (2,808,054) | (1,425,536) | (6,992,485) | (5,510,648) | (3,634,012) | (1,714,942) |
| Laba Kotor | 824,817 | 3,063,410 | 2,445,080 | 1,561,295 | 742,672 | 2,946,473 | 2,353,616 | 1,579,683 | 820,837 |
| Total Beban Usaha | (777,826) | (3,311,581) | (2,407,118) | (1,495,825) | (763,260) | (3,791,000) | (2,655,434) | (1,745,462) | (855,397) |
| Laba Usaha | 46,990 | (248,171) | 37,961 | 65,470 | (20,589) | (844,527) | (301,818) | (165,779) | (34,559) |
| Penghasilan/Beban Lain-Lain | 80,965 | (189,916) | (252,302) | (185,480) | (106,565) | (385,172) | (331,838) | (192,204) | (129,559) |
| Laba Sebelum Pajak | 127,955 | (438,087) | (214,341) | (120,010) | (127,154) | (1,229,699) | (633,656) | (357,983) | (164,119) |
| Beban Pajak Penghasilan | (4,318) | (5,271) | (19,772) | (15,600) | 717 | 21,526 | 82,813 | 45,770 | 22,278 |
| Laba Bersih Dari Operasi Yang Dilanjutkan | 123,637 | (443,357) | (234,114) | (135,610) | (126,437) | (1,208,173) | (550,844) | (312,213) | (141,841) |
| Hak Minoritas | - | - | - | - | - | - | - | - | - |
| Penyesuaian Proforma | - | - | - | - | - | - | - | - | - |
| Laba Bersih Tahun Berjalan | 123,637 | (443,357) | (234,114) | (135,610) | (126,437) | (1,208,173) | (550,844) | (312,213) | (141,841) |
| Pendapatan Komprehensif Lain | - | (251,141) | - | - | - | 103,303 | 4,790 | - | - |
| Jumlah Laba Komprehensif | 123,637 | (694,498) | (234,114) | (135,610) | (126,437) | (1,104,870) | (546,054) | (312,213) | (141,841) |
| Laba Bersih Yang Dapat Diatribusikan | 123,637 | (443,357) | (234,114) | (135,610) | (126,437) | (1,208,173) | (550,844) | (312,213) | (141,841) |
| Laba Komprehensif Yang Dapat Diatribusikan | 123,637 | (694,498) | (234,114) | (135,610) | (126,437) | (1,104,870) | (546,054) | (312,213) | (141,841) |
Key Ratios — KAEF
| Rasio | Q1 2026 ×4 | Q4 2025 | Q3 2025 ×1⅓ | Q2 2025 ×2 | Q1 2025 ×4 | Q4 2024 | Q3 2024 ×1⅓ | Q2 2024 ×2 | Q1 2024 ×4 |
|---|---|---|---|---|---|---|---|---|---|
| Profitabilitas | |||||||||
| Gross Margin (%) | 40.62% | 33.21% | 34.89% | 35.73% | 34.25% | 29.65% | 29.93% | 30.30% | 32.37% |
| Operating Margin (%) | 2.31% | 2.69% | 0.54% | 1.50% | 0.95% | 8.50% | 3.84% | 3.18% | 1.36% |
| Net Margin (%) | 3.67% | 3.63% | 2.56% | 2.17% | 4.71% | 8.47% | 5.36% | 4.35% | 4.05% |
| ROE (%) | 10.06% | 11.61% | 7.38% | 5.70% | 11.75% | 24.58% | 10.55% | 8.23% | 7.29% |
| ROA (%) | 2.07% | 2.36% | 1.61% | 1.27% | 2.72% | 5.63% | 3.35% | 2.66% | 2.37% |
| Per Lembar Saham | |||||||||
| EPS (Rp) | 53,50 | 60,17 | 43,05 | 34,14 | 73,42 | 151,31 | 101,04 | 81,48 | 73,82 |
| BVPS (Rp) | 531,77 | 518,39 | 583,30 | 598,52 | 625,11 | 615,59 | 957,72 | 990,51 | 1.013,02 |
| Valuasi | |||||||||
| PER (x) | 8.45x | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PBV (x) | 0.85x | 0.87x | 0.77x | 0.76x | 0.72x | 0.73x | 0.47x | 0.46x | 0.45x |
| Struktur Modal | |||||||||
| DER (x) | 4.02x | 4.18x | 3.67x | 3.55x | 3.39x | 3.37x | 1.94x | 1.88x | 1.84x |